Obesity, inflammation and endothelial dysfunction

Journal of Biological Regulators and Homeostatic Agents

Volumn 28, Issue 2, 2014, Pages 169-176

  Iantorno, M ^a   Campia, U ^b   Di Daniele, N ^c   Nistico, Steven Paul ^d   Forleo, G B ^c   Cardillo, C ^e   Tesauro, M ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MedStar Cardiovascular Research Network   (United States)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

Atherosclerosis; Endothelial dysfunction; Inflammation; Obesity

Indexed keywords

ANIMALS; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NITRIC OXIDE; OBESITY; PARACRINE COMMUNICATION; TH1 CELLS;

EID: 84905666728     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309:71-82.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 20:235-41.
3. Campia U, Tesauro M, Cardillo C. Human obesity and endothelium-dependent responsiveness. Br J Pharmacol 2012; 165:561-73.
4. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes care 1991; 14:1132-43.
5. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983; 72:1737-47. (Pubitemid 14229053)
6. Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, Ferrannini E. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metab Clin Exp 1987; 36:502-6. (Pubitemid 17072120)
7. Vita JA, Keaney JF, Jr. Endothelial function: a barometer for cardiovascular risk? Circulation 2002; 6:106:640-2. (Pubitemid 34851918)
8. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 13:1285-95. (Pubitemid 46594773)
9. Herman AG, Moncada S. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis. Eur Heart J 2005; 26:1945-55. (Pubitemid 41435726)
10. Kelly JJ, Whitworth JA. Endothelin-1 as a mediator in cardiovascular disease. Clin Exp Pharmacol Physiol 1999; 26:158-61.
11. Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98:121-8. (Pubitemid 43902687)
12. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:257-65. (Pubitemid 34084631)
13. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-10.
14. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007; 28:463-91. (Pubitemid 47236334)
15. Perticone F, Ceravolo R, Candigliota M, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 2001; 50:159-65. (Pubitemid 32047995)
16. Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005; 112:2986-92. (Pubitemid 41612302)
17. Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004; 27:109:1981-6. (Pubitemid 38544488)
18. Cardillo C, Campia U, Iantorno M, Panza JA. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension 2004; 43:36-40. (Pubitemid 38031908)
19. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105:804-9. (Pubitemid 34174919)
20. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112:1785-8. (Pubitemid 38063699)
21. Rask-Madsen C, Dominguez H, Ihlemann N, Hermann T, Kober L, Torp-Pedersen C. Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 2003; 108:1815-21. (Pubitemid 37296090)
22. Mohamed F, Monge JC, Gordon A, Cernacek P, Blais D, Stewart DJ. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscl Thromb Vasc Biol 1995; 15:52-57.
23. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. The J Clin Endocr Metab 2004; 89:447-52. (Pubitemid 38269842)
24. Tesauro M, Schinzari F, Rovella V, et al. Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome. Diabetes Care 2008; 31:1439-41.
25. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocr Metab 2004; 89:2548-56. (Pubitemid 38766330)
26. Greenstein AS, Khavandi K, Withers SB, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119:1661-70.
27. Tesauro M, Canale MP, Rodia G, Di Daniele N, Lauro D, Scuteri A, Cardillo C. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res 2011; 2011:653182.
28. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540-43.
29. Vecchione C, Maffei A, Colella S, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002; 51:168-73. (Pubitemid 34517994)
30. Korda M, Kubant R, Patton S, Malinski T. Leptin-induced endothelial dysfunction in obesity. Am J Physiol 2008; 295:1514-21.
31. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008; 52:1201-10.
32. Schinzari F, Tesauro M, Rovella V, et al. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome. J Clin Endocr Metab 2013; 98:1235-41.
33. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, Olsson T. Leptin is associated with increased risk of myocardial infarction. J Int Med 1999; 246:409-18. (Pubitemid 29479923)
34. Chiarugi P, Fiaschi T. Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration. Exp Op Ther Targ 2010; 14:193-206.
35. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006; 55:249-59. (Pubitemid 43343322)
36. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278:45021-6. (Pubitemid 37377262)
37. Eid HM, Lyberg T, Arnesen H, Seljeflot I. Insulin and adiponectin inhibit the TNF-α-induced ADMA accumulation in human endothelial cells: the role of DDAH. Atherosclerosis 2007; 194:e1-8. (Pubitemid 47513102)
38. Motoshima H, Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. BBRC 2004; 315:264-71. (Pubitemid 38183103)
39. Chen C, Jiang J, Lu JM, Chai H, Wang X, Lin PH, Yao Q. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol 2010; 299:193-201.
40. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 12:736-40. (Pubitemid 36999260)
41. Weikert C, Westphal S, Berger K, et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocr Metabol 2008; 93:2647-53. (Pubitemid 352008532)
42. Tesauro M, Schinzari F, Rovella V, Di Daniele N, Lauro D, Mores N, Veneziani A, Cardillo C. Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. Hypertension 2009; 54:995-1000.
43. Iantorno M, Chen H, Kim JA, Tesauro M, Lauro D, Cardillo C, Quon MJ. Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol 2007; 292:E756-64. (Pubitemid 46411053)
44. Tesauro M, Schinzari F, Caramanti M, Lauro R, Cardillo C. Metabolic and cardiovascular effects of ghrelin. Int J Peptides 2010; pii 864342.
45. Engeli S, Schling P, Gorzelniak K, et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35:807-25. (Pubitemid 36379323)
46. Tham DM, Martin-McNulty B, Wang YX, et al. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiolog Genom 2002; 11:21-30. (Pubitemid 37128718)
47. Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Human Hyperten 2007; 21:20-7. (Pubitemid 44921816)
48. Bendall JK, Alp NJ, Warrick N, et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res 2005; 97:864-71. (Pubitemid 41552671)
49. Schinzari F, Tesauro M, Rovella V, Galli A, Mores N, Porzio O, Lauro D, Cardillo C. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab 2010; 299:E947-52.
50. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113:1888-904. (Pubitemid 43739401)
51. Chiricozzi A, Zhang S, Dattola A, Gabellini S, Chimenti S, Nistico S. Role of Th17 in the pathogenesis of cutaneous inflammatory diseases J Biol Regul Homeost Agents 2012; 26:313-8.
52. Chiricozzi A, Zhang S, Dattola A, Cannizzaro MV, Gabellini M, Chimenti S, Nisticò S. New insights in the pathogenesis of cutaneous autoimmune disorders. J Biol Regul Homeost Agents 2012; 26:165-70.
53. Nisticò S, Chiricozzi A, Saraceno R, Schipani C, Chimenti S. Vitiligo treatment with monochromatic excimer light and tacrolimus: Results of an open randomized controlled study. Photomed Laser Surg 2012; 30:26-30.
54. Specchio F, Carboni I, Chimenti S, Tamburi F, Nisticò S. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Int J Immunopath Pharmacol 2014; 27(1):1-4.
55. Chiricozzi A, Pitocco R, Saraceno R, Nistico SP, Giunta A, Chimenti S. New topical treatments for psoriasis. Exp Op Pharmacother 2014; 15(4):461-70.
56. Nisticò SP, Saraceno R, Chiricozzi A, Giunta A, Di Stefani A, Zerbinati N. UVA-1 Laser in the treatment of palmoplantar pustular psoriasis. Photomed Laser Surg 2013; 31:434-38.
57. Scuteri A, Tesauro M, Rizza S, et al. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis 2008; 18:349-56. (Pubitemid 351749803)